Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perrigo Company plc PRGO

Healthcare
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract... see more

Recent & Breaking News (NYSE:PRGO)

Perrigo to Present at Upcoming Investor Conferences

PR Newswire March 7, 2018

Perrigo Files Form 10-K With SEC; Will Host Fourth Quarter And Calendar Year 2017 Financial Results Conference Call On March 2, 2018

PR Newswire March 1, 2018

Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 Financial Results

PR Newswire March 1, 2018

35 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  February 27, 2018

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  February 27, 2018

Earnings Scheduled For February 27, 2018

Benzinga.com  February 27, 2018

Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results

PR Newswire February 27, 2018

Perrigo Co. Plc to Host Earnings Call

Accesswire February 26, 2018

Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15%

PR Newswire February 20, 2018

Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer

PR Newswire February 20, 2018

Perrigo Announces Quarterly Dividend

PR Newswire February 15, 2018

Perrigo To Release Fourth Quarter And Calendar Year 2017 Financial Results On February 27, 2018

PR Newswire February 8, 2018

Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra® Cream, 1%

PR Newswire January 30, 2018

Perrigo Announces Tentative FDA Approval For The Generic Version Of Onexton® Gel

PR Newswire January 26, 2018

Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream

PR Newswire January 24, 2018

Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo® Gel

PR Newswire January 24, 2018

Perrigo Appoints Uwe Röhrhoff As President & Chief Executive Officer

PR Newswire January 8, 2018

Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07%

PR Newswire January 3, 2018

Perrigo To Present At The 36th Annual J.P. Morgan Healthcare Conference

PR Newswire January 2, 2018

Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo

PR Newswire November 28, 2017